LivaNova (FRA:LIA) Cyclically Adjusted Revenue per Share: €21.80 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LIA LivaNova PLC FRA:LIA
74 GF Score
Price €69.50
GF Value €53.92
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is LivaNova Cyclically Adjusted Revenue per Share?

LivaNova FRA:LIA +0.72% 74 Cyclically Adjusted Revenue per Share is €21.80 as of Mar. 2026. GuruFocus rates FRA:LIA with a GF Score™ of 74/100 and a GF Value™ of €53.92 (Modestly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

LivaNova's adjusted revenue per share for the three months ended in Mar. 2026 was €5.601. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €21.80 for the trailing ten years ended in Mar. 2026.

During the past 12 months, LivaNova's average Cyclically Adjusted Revenue Growth Rate was 5.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 12.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of LivaNova was 23.20% per year. The lowest was 7.80% per year. And the median was 11.60% per year.

As of today (2026-07-18), LivaNova's current stock price is €69.50. LivaNova's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €21.80. LivaNova's Cyclically Adjusted PS Ratio of today is 3.19.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of LivaNova was 10.38. The lowest was 1.39. And the median was 3.91.


LivaNova  (FRA:LIA) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

LivaNova's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=69.50/21.80
=3.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of LivaNova was 10.38. The lowest was 1.39. And the median was 3.91.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


LivaNova Cyclically Adjusted Revenue per Share Related Terms


LivaNova Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for LivaNova's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LivaNova Cyclically Adjusted Revenue per Share Chart

LivaNova Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.86 19.17 20.25 23.07 22.32

LivaNova Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.41 21.76 21.56 22.32 21.80

FRA:LIA vs IRTC, HAE, ITGR: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, LivaNova's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LivaNova Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LivaNova's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where LivaNova's Cyclically Adjusted PS Ratio falls into.


FRA:LIA
74GF Score
LivaNova PLC FRA:LIA
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LivaNova Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, LivaNova's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=5.601/140.8000*140.8000
=5.601

Current CPI (Mar. 2026) = 140.8000.

LivaNova Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 5.812 101.000 8.102
201609 5.361 101.500 7.437
201612 1.191 102.200 1.641
201703 4.402 102.700 6.035
201706 4.714 103.500 6.413
201709 4.343 104.300 5.863
201712 4.801 105.000 6.438
201803 4.129 105.100 5.532
201806 4.988 105.900 6.632
201809 4.794 106.600 6.332
201812 5.378 107.100 7.070
201903 4.601 107.000 6.054
201906 5.074 107.900 6.621
201909 4.996 108.400 6.489
201912 5.347 108.500 6.939
202003 4.498 108.600 5.832
202006 3.328 108.800 4.307
202009 4.190 109.200 5.402
202012 4.557 109.400 5.865
202103 4.268 109.700 5.478
202106 4.487 111.400 5.671
202109 4.173 112.400 5.227
202112 4.485 114.700 5.506
202203 4.025 116.500 4.865
202206 4.446 120.500 5.195
202209 4.766 122.300 5.487
202212 4.853 125.300 5.453
202303 4.565 126.800 5.069
202306 5.025 129.400 5.468
202309 4.966 130.100 5.374
202312 5.216 130.500 5.628
202403 5.024 131.600 5.375
202406 5.421 133.000 5.739
202409 5.251 133.500 5.538
202412 5.617 135.100 5.854
202503 5.386 136.100 5.572
202506 5.587 138.400 5.684
202509 5.527 138.900 5.603
202512 5.645 139.900 5.681
202603 5.601 140.800 5.601

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €21.80 mean?
LivaNova (FRA:LIA) has a Cyclically Adjusted Revenue per Share of €21.80 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on LivaNova and its competitors.
Is LivaNova's Cyclically Adjusted Revenue per Share too high?
LivaNova's current Cyclically Adjusted Revenue per Share is €21.80. Overall, LivaNova has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LivaNova's Cyclically Adjusted Revenue per Share compare to IRTC and HAE?
LivaNova's Cyclically Adjusted Revenue per Share of €21.80 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on LivaNova and its competitors. LivaNova's current Cyclically Adjusted Revenue per Share is €21.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LivaNova stock overvalued right now?
Based on GuruFocus' analysis, LivaNova (FRA:LIA) is currently considered Modestly Overvalued. The stock's GF Value™ is €53.92, compared to a current price of €69.50 — trading 28.9% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €21.80. LivaNova's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For LivaNova (FRA:LIA), the current Cyclically Adjusted Revenue per Share is €21.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LivaNova (FRA:LIA) Overvalued in 2026?

Based on GuruFocus' analysis, LivaNova stock appears to be overvalued. The current stock price of €69.50 is trading 28.9% above its estimated GF Value™ of €53.92. GuruFocus considers LivaNova to be Modestly Overvalued.

Key valuation signals for FRA:LIA:

  • Cyclically Adjusted Revenue per Share: €21.80
  • GF Value™: €53.92 vs. price of €69.50 (28.9% above fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the FRA:LIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LivaNova Business Description

Other Exchanges LIVN:USA
Address 20 Eastbourne Terrace, London, GBR, W2 6LG
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
74GF Score

Get the complete analysis for FRA:LIA

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€69.50
Price
€53.92
GF Value